Patient understanding of disease and the use and outcome of implantable cardioverter defibrillators in hypertrophic cardiomyopathy

Publisher： John Wiley & Sons Inc

E-ISSN： 1540-8159|41|1|57-64

ISSN： 0147-8389

Source： PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol.41, Iss.1, 2018-01, pp. : 57-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Implantable Cardioverter Defibrillators in Dilated Cardiomyopathy

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 13, Iss. S1, 2002-01 ,pp. : S106-S109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of Outcome in Patients with Implantable Cardioverter Defibrillators

By  

Cardiology, Vol. 90, Iss. 3, 2008-10 ,pp. : 180-186

Karger

Access to resources Recommend Favorite

Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 10, 2015-10 ,pp. : 1088-1094

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eligibility for the Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 8, 2015-08 ,pp. : 893-899

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There a Role for Implantable Cardioverter Defibrillators in Long QT Syndrome?

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 13, Iss. S1, 2002-01 ,pp. : S110-S113

John Wiley & Sons Inc

Access to resources Recommend Favorite